Is Revlimid Becoming a Catch-All Cancer Drug?
Celgene has announced that the FDA expanded the existing indication for Revlimid in conjunction with dexamethasone.
Celgene has announced that the FDA expanded the existing indication for Revlimid in conjunction with dexamethasone.
The Federal Reserve on Wednesday afternoon released the minutes of the January 2015 meeting of its Federal Open Market Committee (FOMC).
BMO Capital Markets released its coverage for a major stocks in the oil-and-gas sector. The firm offered three major stocks to buy and two to sell.
The American Customer Satisfaction Index for retail stores and websites was published on Wednesday, and the surprising thing is how thoroughly Wal-Mart is disliked.
ShutterstockThe sharp cuts we have seen to the number of oil rigs working in the United States has not yet translated into lower production. In fact, in two major oil regions, production rose in…
After the U.S. markets close Wednesday, Barrick Gold is scheduled to report its fourth-quarter financial results.
SolarCity is scheduled to report its fourth-quarter financial results Wednesday after the U.S. markets close.
When the predecessor to GM filed for bankruptcy protection in 2009, one item that was mostly left behind for the "old GM" to deal with was liability for crashes that took place before the…
Caterpillar has announced that the SEC is investigating whether it illegally moved money between its U.S. and foreign subsidiaries.
Wednesday before the markets opened, Duke Energy reported disappointing fourth-quarter earnings.
The U.S. Census Bureau and the Department of Housing and Urban Development reported Wednesday morning that new housing starts in January 2015 slipped more than expected.
Even with costs being slashed and share buybacks being halted, it appears that investors who have already taken a hit with share prices dropping should continue to get their quarterly dividend checks.
Hecla Mining reported fourth-quarter and full-year 2014 results before markets opened Wednesday morning.
Neurocrine Biosciences has announced that it will have another public offering of its common stock to raise roughly $225 million.
Midstream master limited partnership (MLP) Phillips 66 Partners on Tuesday priced an underwritten secondary offering of 5.25 million limited partnership units.